Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

Abroad (travel likely)RecruitingPHASE2

Conditions

Lymphoblastic Leukemia · Cancer Survivors · Aplastic Anemia · Myelodysplastic Syndromes · Myeloid Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

City of Hope Medical Center, Duarte, California, United States
Contact: Study coordinator (Lanie Lindenfeld, MA, CCRP) · llindenfeld@coh.org · 626-218-1150
Contact: Principal Investigator (Saro H Armenian, DO, MPH)
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Susan Lee) · leess@chop.edu · 267-602-4603
Contact: Study coordinator (Kristin Wade) · wadekl@chop.edu · 267-398-5761
Contact: Principal Investigator (Sogol Mostoufi-Moab, MD, MSCE)
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Study coordinator (Sarah Terrell, MS) · sarah.terrell@stjude.org · 901-595-4466
Contact: Principal Investigator (Kirsten K. Ness, PhD)

Study leads

Sogol Mostoufi-Moab, MD, MSCE
Principal Investigator
Children's Hospital of Philadelphia

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Myelodysplastic Syndrome

Abroad (travel likely)RecruitingPHASE1

Duarte, United States

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

Acute Myeloid Leukemia · Accelerated Phase Chronic Myeloid Leukemia · Blast Phase Chronic Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Ghent, Belgium · Paris, France

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Seattle, United States

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Acute Lymphoblastic Leukemia in Remission · Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome · Acute Myeloid Leukemia in Remission

Abroad (travel likely)RecruitingPHASE1, PHASE2

Seattle, United States